Bacterial Resistance: A Worldwide Problem
- 1 June 1998
- journal article
- review article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 31 (2), 379-388
- https://doi.org/10.1016/s0732-8893(98)00037-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USADiagnostic Microbiology and Infectious Disease, 1997
- Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical TrialsClinical Infectious Diseases, 1997
- Survey of prevalence of extended spectrum β-lactamases among EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 1996
- Emerging Resistance to Antimicrobial Agents in Gram-Positive BacteriaDrugs, 1996
- Meropenem: a microbiological overviewJournal of Antimicrobial Chemotherapy, 1995
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993Antimicrobial Agents and Chemotherapy, 1994
- Emergence of drug-resistant pneumococcal infections in the United StatesPublished by American Medical Association (AMA) ,1994
- Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum -lactamasesJournal of Antimicrobial Chemotherapy, 1989
- In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidime against clinical isolates from West GermanyJournal of Antimicrobial Chemotherapy, 1989